2238 Hurwitz, Mark - Thomas Jefferson University - Thomas Jefferson University
mdh006

Mark Hurwitz, MD, FACRO

Contact Dr. Hurwitz

111 South 11th Street
Bodine Cancer Center,
Suite G-301
Philadelphia, PA 19107

(215) 955-6644
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. Feasibility of brachytherapy as monotherapy for high-volume, low-risk prostate cancer
  2. Optimization of chest wall hyperthermia treatment using a virtual human chest model
  3. Focused ultrasound for treatment of bone tumours
  4. Is robotic arm stereotactic body radiation therapy 'virtual high-dose rate brachytherapy' effective for prostate cancer? An analysis of comparative effectiveness using published data
  5. International consensus on use of focused ultrasound for painful bone metastases: Current status and future directions
  6. What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation
  7. What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation
  8. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: Phase III trial results
  9. High dose rate brachytherapy boost for prostate cancer: A systematic review
  10. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer
  11. Components of a hyperthermia clinic: Recommendations for staffing, equipment, and treatment monitoring
  12. Hyperthermia, radiation and chemotherapy: The role of heat in multidisciplinary cancer care
  13. The quality frontier
  14. Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
  15. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma
  16. Magnetic resonance-guided focused ultrasound for patients 07CF with painful bone metastases: phase III trial results.
  17. Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer
  18. Evolution of advanced technologies in prostate cancer radiotherapy
  19. Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: Implications for focal therapy
  20. Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiation
0